These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32720420)

  • 1. Auricle perniosis as a manifestation of Covid-19 infection.
    Proietti I; Tolino E; Bernardini N; Mambrin A; Balduzzi V; Marchesiello A; Michelini S; Del Borgo C; Skroza N; Lichtner M; Potenza C
    Dermatol Ther; 2020 Nov; 33(6):e14089. PubMed ID: 32720420
    [No Abstract]   [Full Text] [Related]  

  • 2. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Magro CM; Mulvey JJ; Laurence J; Sanders S; Crowson AN; Grossman M; Harp J; Nuovo G
    Br J Dermatol; 2021 Jan; 184(1):141-150. PubMed ID: 32779733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perniosis in the COVID-19 era.
    Shah I; Stacey SK; Ganne N; Merfeld J
    Dermatol Online J; 2021 May; 27(5):. PubMed ID: 34118825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatology and COVID-19: Much knowledge to date but still a lot to discover.
    Le Cleach L
    Ann Dermatol Venereol; 2021 Jun; 148(2):69-70. PubMed ID: 33781568
    [No Abstract]   [Full Text] [Related]  

  • 6. Dermoscopy features of COVID-19-related chilblains in children and adolescents.
    Navarro L; Andina D; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e762-e764. PubMed ID: 32618033
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestations of COVID-19 in the Franche-Comté region of France: A monocentric study.
    Jacquin-Porretaz C; Ducournau A; Dupond AS; Nardin C; Aubin F; Courtieu C;
    Ann Dermatol Venereol; 2021 Jun; 148(2):124-126. PubMed ID: 33541738
    [No Abstract]   [Full Text] [Related]  

  • 9. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.
    Ko CJ; Harigopal M; Damsky W; Gehlhausen JR; Bosenberg M; Patrignelli R; McNiff JM
    J Cutan Pathol; 2020 Nov; 47(11):997-1002. PubMed ID: 32745281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus (COVID-19) Infection-Induced Chilblains: A Brisk Perieccrine Inflammatory Response.
    Wargo JJ; Weir NM; Shamma HN
    Am J Dermatopathol; 2021 Feb; 43(2):144-145. PubMed ID: 32618705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
    Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W
    J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex regional pain syndrome of the foot in a girl with post-SARS-CoV-2 chilblains.
    Peri F; Della Paolera S; Conversano E; Murru FM; Tommasini A; Taddio A
    Clin Exp Rheumatol; 2022 May; 40(5):1056-1057. PubMed ID: 34874839
    [No Abstract]   [Full Text] [Related]  

  • 13. Chilblains and COVID-19: further evidence against a causal association.
    Baeck M; Peeters C; Herman A
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e2-e3. PubMed ID: 32866323
    [No Abstract]   [Full Text] [Related]  

  • 14. Case did not consider all potential causes of chilblains.
    Dewar CL
    CMAJ; 2020 Sep; 192(36):E1046. PubMed ID: 32900767
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of COVID-19 induced chilblains with topical nitroglycerin.
    Weingarten M; Abittan B; Rivera-Oyola R; Abittan AI; Weingarten M; Lebwohl M
    Int J Dermatol; 2020 Dec; 59(12):1522-1524. PubMed ID: 33084032
    [No Abstract]   [Full Text] [Related]  

  • 16. "COVID Toes" in Three Siblings.
    Feder HM
    Pediatr Infect Dis J; 2021 Dec; 40(12):e488-e490. PubMed ID: 34292264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series.
    Russo R; Cozzani E; Micalizzi C; Parodi A
    Acta Derm Venereol; 2022 May; 102():adv00711. PubMed ID: 35229165
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion.
    Gambichler T; Reuther J; Stücker M; Stranzenbach R; Torres-Reyes C; Schlottmann R; Schmidt WE; Hayajneh R; Sriram A; Becker JC
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e187-e189. PubMed ID: 33002210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chilblains (perniosis).
    Goette DK
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):257-62. PubMed ID: 2212122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East.
    Alramthan A; Aldaraji W
    Clin Exp Dermatol; 2020 Aug; 45(6):746-748. PubMed ID: 32302422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.